申请人:WYETH LLC
公开号:US10022381B2
公开(公告)日:2018-07-17
Compounds of formula I
wherein:
R1 is
and R2, R4, and R6-9 are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase and mTOR, such as a variety of cancers. Methods for making and using the compounds of this invention are disclosed. Various compositions containing the compounds of this invention are also disclosed.
式 I 的化合物
其中
R1 是
和 R2、R4 和 R6-9 在本文中定义,及其药学上可接受的盐和酯。这些化合物抑制 PI3 激酶和 mTOR,可用于治疗由 PI3 激酶和 mTOR 介导的疾病,如各种癌症。本发明公开了制造和使用本发明化合物的方法。还公开了含有本发明化合物的各种组合物。